

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to muscle activity (GO:0014850) | 7.60156769 |
| 2 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 7.35497154 |
| 3 | myofibril assembly (GO:0030239) | 6.65247922 |
| 4 | creatine metabolic process (GO:0006600) | 6.39963637 |
| 5 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 6.33845622 |
| 6 | regulation of relaxation of muscle (GO:1901077) | 6.25978667 |
| 7 | cellular potassium ion homeostasis (GO:0030007) | 6.13914345 |
| 8 | sarcomere organization (GO:0045214) | 5.88443853 |
| 9 | positive regulation of synapse maturation (GO:0090129) | 5.62646038 |
| 10 | response to inactivity (GO:0014854) | 5.54929715 |
| 11 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.54771706 |
| 12 | muscle contraction (GO:0006936) | 5.31476215 |
| 13 | urinary tract smooth muscle contraction (GO:0014848) | 5.31423744 |
| 14 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.29354714 |
| 15 | synaptic vesicle exocytosis (GO:0016079) | 5.20716378 |
| 16 | glutamate secretion (GO:0014047) | 5.18541521 |
| 17 | neurotransmitter-gated ion channel clustering (GO:0072578) | 5.17957240 |
| 18 | glycogen catabolic process (GO:0005980) | 5.15795200 |
| 19 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.15145203 |
| 20 | synaptic vesicle maturation (GO:0016188) | 4.91312330 |
| 21 | cardiac myofibril assembly (GO:0055003) | 4.82513735 |
| 22 | striated muscle atrophy (GO:0014891) | 4.82352455 |
| 23 | glucan catabolic process (GO:0009251) | 4.80779620 |
| 24 | actomyosin structure organization (GO:0031032) | 4.77911743 |
| 25 | protein localization to synapse (GO:0035418) | 4.76499154 |
| 26 | muscle system process (GO:0003012) | 4.73287549 |
| 27 | vocalization behavior (GO:0071625) | 4.70970017 |
| 28 | skeletal muscle tissue development (GO:0007519) | 4.70647777 |
| 29 | skeletal muscle contraction (GO:0003009) | 4.64527966 |
| 30 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.62633354 |
| 31 | retinal rod cell development (GO:0046548) | 4.54713625 |
| 32 | actin-myosin filament sliding (GO:0033275) | 4.53153514 |
| 33 | muscle filament sliding (GO:0030049) | 4.53153514 |
| 34 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 4.51895858 |
| 35 | detection of light stimulus involved in sensory perception (GO:0050962) | 4.48517733 |
| 36 | detection of light stimulus involved in visual perception (GO:0050908) | 4.48517733 |
| 37 | response to pheromone (GO:0019236) | 4.48317473 |
| 38 | cellular polysaccharide catabolic process (GO:0044247) | 4.46426457 |
| 39 | regulation of myoblast differentiation (GO:0045661) | 4.43553764 |
| 40 | regulation of synaptic vesicle transport (GO:1902803) | 4.43264727 |
| 41 | regulation of skeletal muscle contraction (GO:0014819) | 4.41345331 |
| 42 | cardiac muscle contraction (GO:0060048) | 4.36636033 |
| 43 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.36488669 |
| 44 | glycogen biosynthetic process (GO:0005978) | 4.34152192 |
| 45 | glucan biosynthetic process (GO:0009250) | 4.34152192 |
| 46 | regulation of synapse maturation (GO:0090128) | 4.33887675 |
| 47 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.33463222 |
| 48 | muscle atrophy (GO:0014889) | 4.31942833 |
| 49 | striated muscle adaptation (GO:0014888) | 4.31563883 |
| 50 | skeletal muscle tissue regeneration (GO:0043403) | 4.30951337 |
| 51 | muscle fiber development (GO:0048747) | 4.27546518 |
| 52 | potassium ion homeostasis (GO:0055075) | 4.20610333 |
| 53 | regulation of cell communication by electrical coupling (GO:0010649) | 4.19980165 |
| 54 | carnitine shuttle (GO:0006853) | 4.19144345 |
| 55 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.17807836 |
| 56 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.07783764 |
| 57 | positive regulation of myoblast differentiation (GO:0045663) | 4.07221656 |
| 58 | polysaccharide catabolic process (GO:0000272) | 4.02050435 |
| 59 | NADH metabolic process (GO:0006734) | 3.98602309 |
| 60 | gluconeogenesis (GO:0006094) | 3.98374730 |
| 61 | negative regulation of myoblast differentiation (GO:0045662) | 3.96635036 |
| 62 | muscle cell fate commitment (GO:0042693) | 3.95790318 |
| 63 | layer formation in cerebral cortex (GO:0021819) | 3.94687780 |
| 64 | fructose metabolic process (GO:0006000) | 3.93509454 |
| 65 | muscle organ development (GO:0007517) | 3.82368219 |
| 66 | muscle structure development (GO:0061061) | 3.82191362 |
| 67 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.81193422 |
| 68 | actin-mediated cell contraction (GO:0070252) | 3.79177044 |
| 69 | neuronal action potential propagation (GO:0019227) | 3.78411480 |
| 70 | locomotory exploration behavior (GO:0035641) | 3.77155098 |
| 71 | response to activity (GO:0014823) | 3.75983123 |
| 72 | neuromuscular synaptic transmission (GO:0007274) | 3.74582015 |
| 73 | glycogen metabolic process (GO:0005977) | 3.74303618 |
| 74 | cardiac muscle hypertrophy (GO:0003300) | 3.71844891 |
| 75 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.71394601 |
| 76 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.70986001 |
| 77 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.69743980 |
| 78 | muscle adaptation (GO:0043500) | 3.66699897 |
| 79 | plasma membrane repair (GO:0001778) | 3.66567544 |
| 80 | glucan metabolic process (GO:0044042) | 3.65573544 |
| 81 | cellular glucan metabolic process (GO:0006073) | 3.65573544 |
| 82 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.62628469 |
| 83 | hexose biosynthetic process (GO:0019319) | 3.61562808 |
| 84 | regulation of skeletal muscle fiber development (GO:0048742) | 3.60712776 |
| 85 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.58294884 |
| 86 | positive regulation of myotube differentiation (GO:0010831) | 3.56864744 |
| 87 | striated muscle hypertrophy (GO:0014897) | 3.53653959 |
| 88 | neuron cell-cell adhesion (GO:0007158) | 3.51550712 |
| 89 | synaptic vesicle endocytosis (GO:0048488) | 3.50234083 |
| 90 | regulation of actin filament-based movement (GO:1903115) | 3.48056808 |
| 91 | regulation of myotube differentiation (GO:0010830) | 3.42206979 |
| 92 | muscle hypertrophy (GO:0014896) | 3.41964130 |
| 93 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.40935589 |
| 94 | long-term memory (GO:0007616) | 3.40398896 |
| 95 | neurotransmitter secretion (GO:0007269) | 3.37877904 |
| 96 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.36129016 |
| 97 | regulation of neurotransmitter secretion (GO:0046928) | 3.35471472 |
| 98 | positive regulation of membrane potential (GO:0045838) | 3.34529422 |
| 99 | fatty acid transmembrane transport (GO:1902001) | 3.34491739 |
| 100 | 2-oxoglutarate metabolic process (GO:0006103) | 3.32037823 |
| 101 | myoblast fusion (GO:0007520) | 3.32014367 |
| 102 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.31033018 |
| 103 | postsynaptic membrane organization (GO:0001941) | 3.28984797 |
| 104 | myotube differentiation (GO:0014902) | 3.28643509 |
| 105 | striated muscle cell development (GO:0055002) | 3.27411433 |
| 106 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.26469278 |
| 107 | regulation of sarcomere organization (GO:0060297) | 3.25719926 |
| 108 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.25146730 |
| 109 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.25146730 |
| 110 | IMP metabolic process (GO:0046040) | 3.24748991 |
| 111 | muscle organ morphogenesis (GO:0048644) | 3.24090013 |
| 112 | neuromuscular junction development (GO:0007528) | 3.22998866 |
| 113 | cerebellar granule cell differentiation (GO:0021707) | 3.19478482 |
| 114 | striated muscle tissue development (GO:0014706) | 3.18652913 |
| 115 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.18308128 |
| 116 | muscle tissue morphogenesis (GO:0060415) | 3.16452161 |
| 117 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.16371585 |
| 118 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.15538527 |
| 119 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.14460093 |
| 120 | positive regulation of neurotransmitter transport (GO:0051590) | 3.13567376 |
| 121 | carnitine transmembrane transport (GO:1902603) | 3.12713950 |
| 122 | regulation of postsynaptic membrane potential (GO:0060078) | 3.12348045 |
| 123 | regulation of striated muscle contraction (GO:0006942) | 3.11803917 |
| 124 | sodium ion export (GO:0071436) | 3.11472085 |
| 125 | neuron-neuron synaptic transmission (GO:0007270) | 3.11320771 |
| 126 | glycolytic process (GO:0006096) | 3.09988629 |
| 127 | glutamate receptor signaling pathway (GO:0007215) | 3.09603614 |
| 128 | monosaccharide biosynthetic process (GO:0046364) | 3.09409562 |
| 129 | skeletal muscle fiber development (GO:0048741) | 3.08936205 |
| 130 | membrane hyperpolarization (GO:0060081) | 3.08832701 |
| 131 | synaptic transmission, glutamatergic (GO:0035249) | 3.08485468 |
| 132 | regulation of bile acid biosynthetic process (GO:0070857) | 3.07807921 |
| 133 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.04106096 |
| 134 | regulation of the force of heart contraction (GO:0002026) | 3.02583158 |
| 135 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.02381532 |
| 136 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.01911146 |
| 137 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.00862837 |
| 138 | activation of protein kinase A activity (GO:0034199) | 3.00542973 |
| 139 | striated muscle contraction (GO:0006941) | 3.00471615 |
| 140 | regulation of neurotransmitter transport (GO:0051588) | 2.99733546 |
| 141 | negative regulation of necroptotic process (GO:0060546) | 2.99229752 |
| 142 | syncytium formation (GO:0006949) | 2.98225324 |
| 143 | potassium ion import (GO:0010107) | 2.97648914 |
| 144 | membrane depolarization during action potential (GO:0086010) | 2.96931727 |
| 145 | actin filament-based movement (GO:0030048) | 2.94928939 |
| 146 | positive regulation of muscle hypertrophy (GO:0014742) | 2.94326880 |
| 147 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.94326880 |
| 148 | righting reflex (GO:0060013) | 2.94227095 |
| 149 | regulation of synapse structural plasticity (GO:0051823) | 2.94119218 |
| 150 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 2.91159290 |
| 151 | adult heart development (GO:0007512) | 2.90889162 |
| 152 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.90591103 |
| 153 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.89887648 |
| 154 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.88986384 |
| 155 | tricarboxylic acid cycle (GO:0006099) | 2.88868268 |
| 156 | 4-hydroxyproline metabolic process (GO:0019471) | 2.88472231 |
| 157 | response to histamine (GO:0034776) | 2.88026854 |
| 158 | negative regulation of cell size (GO:0045792) | 2.87670201 |
| 159 | regulation of membrane repolarization (GO:0060306) | 2.87489346 |
| 160 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.87161734 |
| 161 | carnitine transport (GO:0015879) | 2.87130842 |
| 162 | amino-acid betaine transport (GO:0015838) | 2.87130842 |
| 163 | muscle cell cellular homeostasis (GO:0046716) | 2.87117371 |
| 164 | cardiac muscle cell development (GO:0055013) | 2.87001814 |
| 165 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.86217926 |
| 166 | innervation (GO:0060384) | 2.85710580 |
| 167 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.85595657 |
| 168 | long-term synaptic potentiation (GO:0060291) | 2.84355030 |
| 169 | neurotransmitter transport (GO:0006836) | 2.82603933 |
| 170 | skeletal muscle adaptation (GO:0043501) | 2.81050806 |
| 171 | myotube cell development (GO:0014904) | 2.79003005 |
| 172 | negative regulation of cation channel activity (GO:2001258) | 2.78782616 |
| 173 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.77023737 |
| 174 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.77023737 |
| 175 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.76931557 |
| 176 | regulation of cation channel activity (GO:2001257) | 2.76629089 |
| 177 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.75059598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.19946242 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.37034181 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.51647329 |
| 4 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.47773469 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.85968558 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.79234206 |
| 7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.75646123 |
| 8 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.75646123 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.72637824 |
| 10 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.56445858 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.49895751 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.48879188 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.40090947 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.40090947 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.39039129 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.33414073 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.31975684 |
| 18 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.31456448 |
| 19 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.28913291 |
| 20 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.26556369 |
| 21 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.25814175 |
| 22 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.23558886 |
| 23 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.18493632 |
| 24 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.17668211 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.13589331 |
| 26 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.13266254 |
| 27 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.13108675 |
| 28 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.09735202 |
| 29 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 2.08960683 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.01140512 |
| 31 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.96487336 |
| 32 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.95899869 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.90516198 |
| 34 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.87009591 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.86853374 |
| 36 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.86756343 |
| 37 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85988166 |
| 38 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.84823191 |
| 39 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.84818221 |
| 40 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.83500844 |
| 41 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.83456060 |
| 42 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.82009776 |
| 43 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.75319936 |
| 44 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.73336706 |
| 45 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.73056402 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.72859754 |
| 47 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.69977937 |
| 48 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.69940025 |
| 49 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.69486732 |
| 50 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.67138740 |
| 51 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.66212486 |
| 52 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.60750295 |
| 53 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.60182038 |
| 54 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.59949502 |
| 55 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.59482867 |
| 56 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.58492702 |
| 57 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.58267546 |
| 58 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.57427299 |
| 59 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.56607843 |
| 60 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.55570484 |
| 61 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.55166314 |
| 62 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.54213243 |
| 63 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52608640 |
| 64 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52597048 |
| 65 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.52152409 |
| 66 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.50650766 |
| 67 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.48162186 |
| 68 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.45820221 |
| 69 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.45160882 |
| 70 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.43985073 |
| 71 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.43278340 |
| 72 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.41851554 |
| 73 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.40354819 |
| 74 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.39136517 |
| 75 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.38324854 |
| 76 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.37474875 |
| 77 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.36680211 |
| 78 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.35394141 |
| 79 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.35153547 |
| 80 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.34098647 |
| 81 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.33301433 |
| 82 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.33188155 |
| 83 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.32750089 |
| 84 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.31807769 |
| 85 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29943146 |
| 86 | AR_19668381_ChIP-Seq_PC3_Human | 1.29869414 |
| 87 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.28838836 |
| 88 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28380039 |
| 89 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.27701766 |
| 90 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26860858 |
| 91 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.26827845 |
| 92 | P68_20966046_ChIP-Seq_HELA_Human | 1.25936373 |
| 93 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25453200 |
| 94 | AR_25329375_ChIP-Seq_VCAP_Human | 1.24822475 |
| 95 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24250210 |
| 96 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.24060739 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.24032829 |
| 98 | STAT3_23295773_ChIP-Seq_U87_Human | 1.22852438 |
| 99 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.21272301 |
| 100 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.20654300 |
| 101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.20607241 |
| 102 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.20196028 |
| 103 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19559867 |
| 104 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.19439744 |
| 105 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.18683411 |
| 106 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.18428588 |
| 107 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.18295343 |
| 108 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.18009587 |
| 109 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17601979 |
| 110 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15916767 |
| 111 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.15868420 |
| 112 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.15110781 |
| 113 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.13534498 |
| 114 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.13199981 |
| 115 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.13160914 |
| 116 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.12951423 |
| 117 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.12434878 |
| 118 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09327552 |
| 119 | * CTCF_27219007_Chip-Seq_Bcells_Human | 1.08695268 |
| 120 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08349486 |
| 121 | P300_19829295_ChIP-Seq_ESCs_Human | 1.07852225 |
| 122 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07769417 |
| 123 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.07652059 |
| 124 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.06908750 |
| 125 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.06825157 |
| 126 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05127445 |
| 127 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04565203 |
| 128 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.02665156 |
| 129 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.02612644 |
| 130 | KDM2B_26808549_Chip-Seq_K562_Human | 1.01897151 |
| 131 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.01706508 |
| 132 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.01706508 |
| 133 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00665887 |
| 134 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.00524728 |
| 135 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.99737652 |
| 136 | * JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.99173287 |
| 137 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.99049155 |
| 138 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.98770099 |
| 139 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98699616 |
| 140 | * SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.97864838 |
| 141 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.97605048 |
| 142 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97339925 |
| 143 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.96663342 |
| 144 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.96063656 |
| 145 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.96006120 |
| 146 | FUS_26573619_Chip-Seq_HEK293_Human | 0.95762022 |
| 147 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.95761283 |
| 148 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.95749578 |
| 149 | TP53_16413492_ChIP-PET_HCT116_Human | 0.95659106 |
| 150 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.94667796 |
| 151 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.94119107 |
| 152 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.93792148 |
| 153 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.93425840 |
| 154 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93117785 |
| 155 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.92480958 |
| 156 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.92030410 |
| 157 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.92023051 |
| 158 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.91991089 |
| 159 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91802858 |
| 160 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.91784309 |
| 161 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.91240079 |
| 162 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90302195 |
| 163 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.89192761 |
| 164 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.88632643 |
| 165 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.87962406 |
| 166 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.87862873 |
| 167 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.87854689 |
| 168 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.87670709 |
| 169 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.87556513 |
| 170 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.87489565 |
| 171 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.86918277 |
| 172 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.86595491 |
| 173 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86554409 |
| 174 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.86515528 |
| 175 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.85732989 |
| 176 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.85194545 |
| 177 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.84109627 |
| 178 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.83800393 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 4.21315156 |
| 2 | MP0005451_abnormal_body_composition | 4.20362373 |
| 3 | MP0004859_abnormal_synaptic_plasticity | 4.11422653 |
| 4 | MP0000751_myopathy | 4.06807924 |
| 5 | MP0000749_muscle_degeneration | 3.86053922 |
| 6 | MP0004270_analgesia | 3.65735335 |
| 7 | MP0003880_abnormal_central_pattern | 3.22120146 |
| 8 | MP0004233_abnormal_muscle_weight | 3.01077289 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 2.93813039 |
| 10 | MP0003635_abnormal_synaptic_transmissio | 2.77570770 |
| 11 | MP0000747_muscle_weakness | 2.76662442 |
| 12 | MP0002090_abnormal_vision | 2.62943003 |
| 13 | MP0004036_abnormal_muscle_relaxation | 2.46395175 |
| 14 | MP0009046_muscle_twitch | 2.43982508 |
| 15 | MP0000013_abnormal_adipose_tissue | 2.42095073 |
| 16 | MP0003646_muscle_fatigue | 2.32598650 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.32507075 |
| 18 | MP0002734_abnormal_mechanical_nocicepti | 2.32481659 |
| 19 | MP0001968_abnormal_touch/_nociception | 2.32195308 |
| 20 | MP0001984_abnormal_olfaction | 2.24917762 |
| 21 | MP0002106_abnormal_muscle_physiology | 2.22616185 |
| 22 | MP0003879_abnormal_hair_cell | 2.19091277 |
| 23 | MP0002269_muscular_atrophy | 2.13535039 |
| 24 | MP0001486_abnormal_startle_reflex | 2.05892064 |
| 25 | MP0009745_abnormal_behavioral_response | 2.03939625 |
| 26 | MP0002063_abnormal_learning/memory/cond | 2.03531651 |
| 27 | MP0002064_seizures | 2.01703154 |
| 28 | MP0010386_abnormal_urinary_bladder | 2.00845277 |
| 29 | MP0004087_abnormal_muscle_fiber | 1.99069135 |
| 30 | MP0005369_muscle_phenotype | 1.96065469 |
| 31 | MP0002837_dystrophic_cardiac_calcinosis | 1.95667633 |
| 32 | MP0000750_abnormal_muscle_regeneration | 1.91098551 |
| 33 | MP0005620_abnormal_muscle_contractility | 1.90674788 |
| 34 | MP0008569_lethality_at_weaning | 1.90569130 |
| 35 | MP0005423_abnormal_somatic_nervous | 1.84449874 |
| 36 | MP0002272_abnormal_nervous_system | 1.82976085 |
| 37 | MP0000569_abnormal_digit_pigmentation | 1.79388196 |
| 38 | MP0002736_abnormal_nociception_after | 1.73302955 |
| 39 | MP0002572_abnormal_emotion/affect_behav | 1.71305425 |
| 40 | MP0004130_abnormal_muscle_cell | 1.67881664 |
| 41 | MP0002067_abnormal_sensory_capabilities | 1.67538299 |
| 42 | MP0002909_abnormal_adrenal_gland | 1.64121342 |
| 43 | MP0006036_abnormal_mitochondrial_physio | 1.62149716 |
| 44 | MP0002822_catalepsy | 1.61884531 |
| 45 | MP0000003_abnormal_adipose_tissue | 1.61548882 |
| 46 | MP0006138_congestive_heart_failure | 1.58386452 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.47152896 |
| 48 | MP0002184_abnormal_innervation | 1.46917415 |
| 49 | MP0001502_abnormal_circadian_rhythm | 1.41197275 |
| 50 | MP0002108_abnormal_muscle_morphology | 1.40360026 |
| 51 | MP0010630_abnormal_cardiac_muscle | 1.36483395 |
| 52 | MP0002234_abnormal_pharynx_morphology | 1.36420927 |
| 53 | MP0004510_myositis | 1.36339318 |
| 54 | MP0001440_abnormal_grooming_behavior | 1.34794211 |
| 55 | MP0004215_abnormal_myocardial_fiber | 1.34287542 |
| 56 | MP0000733_abnormal_muscle_development | 1.31388819 |
| 57 | MP0005670_abnormal_white_adipose | 1.30911008 |
| 58 | MP0005266_abnormal_metabolism | 1.28797645 |
| 59 | MP0004185_abnormal_adipocyte_glucose | 1.26745769 |
| 60 | MP0005375_adipose_tissue_phenotype | 1.26627077 |
| 61 | MP0003868_abnormal_feces_composition | 1.19961908 |
| 62 | MP0004043_abnormal_pH_regulation | 1.18778899 |
| 63 | MP0002882_abnormal_neuron_morphology | 1.16862120 |
| 64 | MP0002332_abnormal_exercise_endurance | 1.16176836 |
| 65 | MP0006072_abnormal_retinal_apoptosis | 1.15946191 |
| 66 | MP0004811_abnormal_neuron_physiology | 1.14441713 |
| 67 | MP0001661_extended_life_span | 1.13949988 |
| 68 | MP0002735_abnormal_chemical_nociception | 1.10029236 |
| 69 | MP0001529_abnormal_vocalization | 1.06062396 |
| 70 | MP0002127_abnormal_cardiovascular_syste | 1.05540759 |
| 71 | MP0005253_abnormal_eye_physiology | 1.04458903 |
| 72 | MP0005623_abnormal_meninges_morphology | 1.04444425 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.04282186 |
| 74 | MP0002229_neurodegeneration | 1.03473218 |
| 75 | MP0005666_abnormal_adipose_tissue | 1.02327358 |
| 76 | MP0001501_abnormal_sleep_pattern | 1.02186745 |
| 77 | MP0004924_abnormal_behavior | 1.01295627 |
| 78 | MP0005386_behavior/neurological_phenoty | 1.01295627 |
| 79 | MP0002557_abnormal_social/conspecific_i | 1.00314010 |
| 80 | MP0005385_cardiovascular_system_phenoty | 0.99515788 |
| 81 | MP0001544_abnormal_cardiovascular_syste | 0.99515788 |
| 82 | MP0003045_fibrosis | 0.98401783 |
| 83 | MP0008775_abnormal_heart_ventricle | 0.95816016 |
| 84 | MP0003950_abnormal_plasma_membrane | 0.93569428 |
| 85 | MP0000955_abnormal_spinal_cord | 0.92619865 |
| 86 | MP0006292_abnormal_olfactory_placode | 0.91730412 |
| 87 | MP0004084_abnormal_cardiac_muscle | 0.91455920 |
| 88 | MP0003221_abnormal_cardiomyocyte_apopto | 0.90668171 |
| 89 | MP0002752_abnormal_somatic_nervous | 0.89866698 |
| 90 | MP0000579_abnormal_nail_morphology | 0.89697260 |
| 91 | MP0005195_abnormal_posterior_eye | 0.89590711 |
| 92 | MP0003633_abnormal_nervous_system | 0.88908604 |
| 93 | MP0000762_abnormal_tongue_morphology | 0.87636579 |
| 94 | MP0002972_abnormal_cardiac_muscle | 0.86324296 |
| 95 | MP0001970_abnormal_pain_threshold | 0.85408699 |
| 96 | MP0005394_taste/olfaction_phenotype | 0.82773760 |
| 97 | MP0005499_abnormal_olfactory_system | 0.82773760 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.79581901 |
| 99 | MP0001299_abnormal_eye_distance/ | 0.78665713 |
| 100 | MP0004085_abnormal_heartbeat | 0.78560853 |
| 101 | MP0003091_abnormal_cell_migration | 0.76894643 |
| 102 | MP0005330_cardiomyopathy | 0.76794325 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.75324716 |
| 104 | MP0008789_abnormal_olfactory_epithelium | 0.73116466 |
| 105 | MP0010030_abnormal_orbit_morphology | 0.72521605 |
| 106 | MP0005503_abnormal_tendon_morphology | 0.72152601 |
| 107 | MP0002896_abnormal_bone_mineralization | 0.71984015 |
| 108 | MP0003705_abnormal_hypodermis_morpholog | 0.71752995 |
| 109 | MP0002638_abnormal_pupillary_reflex | 0.70332864 |
| 110 | MP0005187_abnormal_penis_morphology | 0.68417928 |
| 111 | MP0004484_altered_response_of | 0.66848924 |
| 112 | MP0002971_abnormal_brown_adipose | 0.66747798 |
| 113 | MP0010368_abnormal_lymphatic_system | 0.66352368 |
| 114 | MP0008872_abnormal_physiological_respon | 0.65571102 |
| 115 | MP0003631_nervous_system_phenotype | 0.65181924 |
| 116 | MP0001348_abnormal_lacrimal_gland | 0.64914156 |
| 117 | MP0003787_abnormal_imprinting | 0.64590881 |
| 118 | MP0001943_abnormal_respiration | 0.63872612 |
| 119 | MP0001727_abnormal_embryo_implantation | 0.63804303 |
| 120 | MP0003890_abnormal_embryonic-extraembry | 0.63050336 |
| 121 | MP0005257_abnormal_intraocular_pressure | 0.62980782 |
| 122 | MP0004858_abnormal_nervous_system | 0.62931586 |
| 123 | MP0003329_amyloid_beta_deposits | 0.60526499 |
| 124 | MP0002069_abnormal_eating/drinking_beha | 0.60199790 |
| 125 | MP0001177_atelectasis | 0.60103045 |
| 126 | MP0005646_abnormal_pituitary_gland | 0.59994837 |
| 127 | MP0005535_abnormal_body_temperature | 0.59218862 |
| 128 | MP0002089_abnormal_postnatal_growth/wei | 0.58050810 |
| 129 | MP0000681_abnormal_thyroid_gland | 0.57726974 |
| 130 | MP0000266_abnormal_heart_morphology | 0.57692735 |
| 131 | MP0003137_abnormal_impulse_conducting | 0.56202628 |
| 132 | MP0008874_decreased_physiological_sensi | 0.55421677 |
| 133 | MP0002114_abnormal_axial_skeleton | 0.53765598 |
| 134 | MP0001958_emphysema | 0.52920604 |
| 135 | MP0008438_abnormal_cutaneous_collagen | 0.51624168 |
| 136 | MP0003828_pulmonary_edema | 0.46860105 |
| 137 | MP0001849_ear_inflammation | 0.45886042 |
| 138 | MP0000534_abnormal_ureter_morphology | 0.45425476 |
| 139 | MP0005076_abnormal_cell_differentiation | 0.45210078 |
| 140 | MP0009250_abnormal_appendicular_skeleto | 0.43235541 |
| 141 | MP0002078_abnormal_glucose_homeostasis | 0.41271294 |
| 142 | MP0003385_abnormal_body_wall | 0.39348363 |
| 143 | MP0003315_abnormal_perineum_morphology | 0.38751931 |
| 144 | MP0002128_abnormal_blood_circulation | 0.38023195 |
| 145 | MP0005332_abnormal_amino_acid | 0.37824050 |
| 146 | MP0003806_abnormal_nucleotide_metabolis | 0.36873889 |
| 147 | MP0002249_abnormal_larynx_morphology | 0.36806631 |
| 148 | MP0003656_abnormal_erythrocyte_physiolo | 0.36800015 |
| 149 | MP0004134_abnormal_chest_morphology | 0.34682298 |
| 150 | MP0001346_abnormal_lacrimal_gland | 0.34583427 |
| 151 | MP0005165_increased_susceptibility_to | 0.34539593 |
| 152 | MP0003948_abnormal_gas_homeostasis | 0.34187035 |
| 153 | MP0008770_decreased_survivor_rate | 0.32998360 |
| 154 | MP0009840_abnormal_foam_cell | 0.30497906 |
| 155 | MP0004272_abnormal_basement_membrane | 0.30449172 |
| 156 | MP0005376_homeostasis/metabolism_phenot | 0.30249362 |
| 157 | MP0005023_abnormal_wound_healing | 0.30010524 |
| 158 | MP0005167_abnormal_blood-brain_barrier | 0.29562699 |
| 159 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.28274191 |
| 160 | MP0005334_abnormal_fat_pad | 0.27015019 |
| 161 | MP0005452_abnormal_adipose_tissue | 0.25323788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Congenital stationary night blindness (HP:0007642) | 6.46194762 |
| 2 | Exercise-induced myalgia (HP:0003738) | 6.17699377 |
| 3 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.08376666 |
| 4 | Muscle fiber inclusion bodies (HP:0100299) | 5.97561647 |
| 5 | Nemaline bodies (HP:0003798) | 5.52241567 |
| 6 | Round ear (HP:0100830) | 5.46546622 |
| 7 | Type 1 muscle fiber predominance (HP:0003803) | 5.31029662 |
| 8 | Fetal akinesia sequence (HP:0001989) | 5.21146461 |
| 9 | Exercise-induced muscle cramps (HP:0003710) | 4.84912302 |
| 10 | Myopathic facies (HP:0002058) | 4.81118431 |
| 11 | Distal arthrogryposis (HP:0005684) | 4.78506974 |
| 12 | Rhabdomyolysis (HP:0003201) | 4.63945384 |
| 13 | Distal lower limb muscle weakness (HP:0009053) | 4.63312123 |
| 14 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.23206005 |
| 15 | Epileptic encephalopathy (HP:0200134) | 4.10883993 |
| 16 | Focal motor seizures (HP:0011153) | 4.06588091 |
| 17 | Calf muscle hypertrophy (HP:0008981) | 4.04961310 |
| 18 | Popliteal pterygium (HP:0009756) | 3.95807082 |
| 19 | Asymmetric septal hypertrophy (HP:0001670) | 3.78478004 |
| 20 | Difficulty running (HP:0009046) | 3.73329612 |
| 21 | Rimmed vacuoles (HP:0003805) | 3.71728458 |
| 22 | Abnormality of the calf musculature (HP:0001430) | 3.66377092 |
| 23 | Ulnar deviation of the wrist (HP:0003049) | 3.66037118 |
| 24 | Areflexia of lower limbs (HP:0002522) | 3.54813409 |
| 25 | Absence seizures (HP:0002121) | 3.51984285 |
| 26 | Abnormality of the neuromuscular junction (HP:0003398) | 3.50970617 |
| 27 | Fatigable weakness (HP:0003473) | 3.50970617 |
| 28 | Central scotoma (HP:0000603) | 3.48973250 |
| 29 | Malignant hyperthermia (HP:0002047) | 3.43607881 |
| 30 | Type 2 muscle fiber atrophy (HP:0003554) | 3.40347379 |
| 31 | Abnormality of macular pigmentation (HP:0008002) | 3.38259590 |
| 32 | EMG: myopathic abnormalities (HP:0003458) | 3.30620797 |
| 33 | Gowers sign (HP:0003391) | 3.21207381 |
| 34 | Muscle fiber splitting (HP:0003555) | 3.18658413 |
| 35 | Bundle branch block (HP:0011710) | 3.09537730 |
| 36 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.08880785 |
| 37 | Febrile seizures (HP:0002373) | 3.08346145 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 3.07750248 |
| 39 | Difficulty climbing stairs (HP:0003551) | 3.02208817 |
| 40 | Increased variability in muscle fiber diameter (HP:0003557) | 2.99333209 |
| 41 | Atonic seizures (HP:0010819) | 2.95255360 |
| 42 | Deformed tarsal bones (HP:0008119) | 2.94670288 |
| 43 | Weak cry (HP:0001612) | 2.90666592 |
| 44 | Abnormality of the calcaneus (HP:0008364) | 2.87747746 |
| 45 | Calcaneovalgus deformity (HP:0001848) | 2.86705514 |
| 46 | Muscle fiber atrophy (HP:0100295) | 2.86132586 |
| 47 | Generalized tonic-clonic seizures (HP:0002069) | 2.84440863 |
| 48 | Dialeptic seizures (HP:0011146) | 2.84132710 |
| 49 | Absent phalangeal crease (HP:0006109) | 2.83962989 |
| 50 | Amniotic constriction ring (HP:0009775) | 2.82159731 |
| 51 | Abnormality of placental membranes (HP:0011409) | 2.82159731 |
| 52 | Spinal rigidity (HP:0003306) | 2.79512270 |
| 53 | Increased corneal curvature (HP:0100692) | 2.73040372 |
| 54 | Keratoconus (HP:0000563) | 2.73040372 |
| 55 | Increased connective tissue (HP:0009025) | 2.72423379 |
| 56 | Shoulder girdle muscle weakness (HP:0003547) | 2.71670478 |
| 57 | Focal seizures (HP:0007359) | 2.67183177 |
| 58 | Severe visual impairment (HP:0001141) | 2.66195630 |
| 59 | Nonprogressive disorder (HP:0003680) | 2.64982023 |
| 60 | Akinesia (HP:0002304) | 2.63212044 |
| 61 | Bulbar palsy (HP:0001283) | 2.57799091 |
| 62 | Aplasia of the musculature (HP:0100854) | 2.53917163 |
| 63 | Myotonia (HP:0002486) | 2.51304304 |
| 64 | Myoglobinuria (HP:0002913) | 2.49985321 |
| 65 | Progressive muscle weakness (HP:0003323) | 2.44656444 |
| 66 | Visual hallucinations (HP:0002367) | 2.44173800 |
| 67 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.37447351 |
| 68 | Abnormality of the foot musculature (HP:0001436) | 2.32612632 |
| 69 | Foot dorsiflexor weakness (HP:0009027) | 2.32136835 |
| 70 | Abnormal finger flexion creases (HP:0006143) | 2.29283934 |
| 71 | Pelvic girdle muscle weakness (HP:0003749) | 2.28272896 |
| 72 | Neck muscle weakness (HP:0000467) | 2.27460702 |
| 73 | Slender build (HP:0001533) | 2.27117955 |
| 74 | Frequent falls (HP:0002359) | 2.26306492 |
| 75 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.24517129 |
| 76 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.24517129 |
| 77 | Muscle stiffness (HP:0003552) | 2.24295438 |
| 78 | Scotoma (HP:0000575) | 2.23726639 |
| 79 | Decreased central vision (HP:0007663) | 2.22826650 |
| 80 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.21093758 |
| 81 | Stridor (HP:0010307) | 2.17200407 |
| 82 | Lipoatrophy (HP:0100578) | 2.15581540 |
| 83 | Dilated cardiomyopathy (HP:0001644) | 2.14867604 |
| 84 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.12878304 |
| 85 | Dysmetric saccades (HP:0000641) | 2.10861264 |
| 86 | Epileptiform EEG discharges (HP:0011182) | 2.10844979 |
| 87 | Progressive cerebellar ataxia (HP:0002073) | 2.10217861 |
| 88 | EEG with generalized epileptiform discharges (HP:0011198) | 2.09314282 |
| 89 | Gaze-evoked nystagmus (HP:0000640) | 2.08755326 |
| 90 | Myokymia (HP:0002411) | 2.08738592 |
| 91 | Hyperkalemia (HP:0002153) | 2.07341882 |
| 92 | Distal lower limb amyotrophy (HP:0008944) | 2.07187705 |
| 93 | Ventricular tachycardia (HP:0004756) | 2.06254903 |
| 94 | Lower limb amyotrophy (HP:0007210) | 2.06034896 |
| 95 | Generalized muscle weakness (HP:0003324) | 2.03036414 |
| 96 | Abnormal gallbladder physiology (HP:0012438) | 2.02573502 |
| 97 | Cholecystitis (HP:0001082) | 2.02573502 |
| 98 | EMG: neuropathic changes (HP:0003445) | 2.02285964 |
| 99 | Waddling gait (HP:0002515) | 2.02180405 |
| 100 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.02112349 |
| 101 | Wrist flexion contracture (HP:0001239) | 1.99546576 |
| 102 | Widely spaced teeth (HP:0000687) | 1.98644467 |
| 103 | Proximal amyotrophy (HP:0007126) | 1.98010244 |
| 104 | Ulnar bowing (HP:0003031) | 1.97122959 |
| 105 | Prolonged QT interval (HP:0001657) | 1.97012146 |
| 106 | Dysdiadochokinesis (HP:0002075) | 1.96887250 |
| 107 | Abnormal atrioventricular conduction (HP:0005150) | 1.96667286 |
| 108 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.94241749 |
| 109 | Ankle clonus (HP:0011448) | 1.93227824 |
| 110 | Abnormal rod and cone electroretinograms (HP:0008323) | 1.93052515 |
| 111 | Hip contracture (HP:0003273) | 1.92065619 |
| 112 | Heart block (HP:0012722) | 1.90892176 |
| 113 | Sudden death (HP:0001699) | 1.90736118 |
| 114 | Broad-based gait (HP:0002136) | 1.87521218 |
| 115 | Muscular dystrophy (HP:0003560) | 1.85844162 |
| 116 | Abnormality of the lower motor neuron (HP:0002366) | 1.84678664 |
| 117 | Ventricular fibrillation (HP:0001663) | 1.82730579 |
| 118 | Limb-girdle muscle atrophy (HP:0003797) | 1.81925468 |
| 119 | Limb-girdle muscle weakness (HP:0003325) | 1.79216084 |
| 120 | Easy fatigability (HP:0003388) | 1.78946699 |
| 121 | Scapular winging (HP:0003691) | 1.78856678 |
| 122 | Abnormality of the left ventricular outflow tract (HP:0011103) | 1.78700521 |
| 123 | Subaortic stenosis (HP:0001682) | 1.78700521 |
| 124 | Achilles tendon contracture (HP:0001771) | 1.71951346 |
| 125 | Congenital hip dislocation (HP:0001374) | 1.69518198 |
| 126 | Broad face (HP:0000283) | 1.64830415 |
| 127 | Ulnar deviation of finger (HP:0009465) | 1.62709418 |
| 128 | Steppage gait (HP:0003376) | 1.58884094 |
| 129 | Metatarsus adductus (HP:0001840) | 1.55112106 |
| 130 | Long clavicles (HP:0000890) | 1.54513364 |
| 131 | Abnormality of the Achilles tendon (HP:0005109) | 1.52182841 |
| 132 | Ragged-red muscle fibers (HP:0003200) | 1.49095456 |
| 133 | Limited hip movement (HP:0008800) | 1.48432262 |
| 134 | Atrioventricular block (HP:0001678) | 1.48250580 |
| 135 | Generalized amyotrophy (HP:0003700) | 1.46611868 |
| 136 | Absent frontal sinuses (HP:0002688) | 1.45487366 |
| 137 | Fragile skin (HP:0001030) | 1.45207861 |
| 138 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.43638385 |
| 139 | Osteolytic defects of the hand bones (HP:0009699) | 1.43638385 |
| 140 | Facial diplegia (HP:0001349) | 1.40770954 |
| 141 | Abnormality of oral frenula (HP:0000190) | 1.40665619 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 3.84835547 |
| 2 | MAPKAPK3 | 3.34555001 |
| 3 | PAK6 | 3.10303519 |
| 4 | DAPK2 | 3.06667338 |
| 5 | PHKG2 | 2.93965351 |
| 6 | PHKG1 | 2.93965351 |
| 7 | NME1 | 2.86157414 |
| 8 | EPHA4 | 2.77254973 |
| 9 | STK38L | 2.47176376 |
| 10 | STK38 | 2.42926393 |
| 11 | PRKD3 | 2.31606628 |
| 12 | MAP3K4 | 2.31284420 |
| 13 | OBSCN | 2.28962691 |
| 14 | PRPF4B | 2.28149361 |
| 15 | MAP3K9 | 2.25904637 |
| 16 | TRPM7 | 1.99273116 |
| 17 | PINK1 | 1.98144277 |
| 18 | MARK1 | 1.97591784 |
| 19 | MAP2K4 | 1.93897222 |
| 20 | MAP3K13 | 1.89648772 |
| 21 | NEK1 | 1.85086967 |
| 22 | CASK | 1.84954319 |
| 23 | NTRK3 | 1.83808375 |
| 24 | MAP2K7 | 1.82572423 |
| 25 | MAP3K7 | 1.78275074 |
| 26 | TTN | 1.72785832 |
| 27 | EEF2K | 1.62442024 |
| 28 | RIPK1 | 1.62220904 |
| 29 | MINK1 | 1.53624434 |
| 30 | MAP2K3 | 1.52399020 |
| 31 | PIK3CG | 1.47163352 |
| 32 | RPS6KB2 | 1.38540346 |
| 33 | MUSK | 1.36779370 |
| 34 | KSR2 | 1.34477474 |
| 35 | DAPK1 | 1.27669416 |
| 36 | IRAK3 | 1.27021082 |
| 37 | MST1R | 1.26220139 |
| 38 | CAMKK1 | 1.25867340 |
| 39 | ICK | 1.22303317 |
| 40 | CAMK1G | 1.22239612 |
| 41 | FES | 1.19467768 |
| 42 | CDK5 | 1.07250876 |
| 43 | CAMK1 | 1.06716107 |
| 44 | LIMK1 | 1.05914685 |
| 45 | MAPK12 | 1.05684204 |
| 46 | PAK2 | 0.97193617 |
| 47 | CDK3 | 0.96568102 |
| 48 | NTRK2 | 0.92651168 |
| 49 | RPS6KA2 | 0.92160741 |
| 50 | PLK2 | 0.91884827 |
| 51 | PDK1 | 0.90190374 |
| 52 | TAOK2 | 0.89995456 |
| 53 | SIK2 | 0.87456059 |
| 54 | PRKAA1 | 0.87269272 |
| 55 | PIK3CA | 0.85589798 |
| 56 | MARK2 | 0.82482030 |
| 57 | INSRR | 0.80954605 |
| 58 | PKN1 | 0.80889450 |
| 59 | PRKD2 | 0.79880970 |
| 60 | PTK2B | 0.79557948 |
| 61 | CAMK1D | 0.78933292 |
| 62 | PRKCH | 0.78550407 |
| 63 | KSR1 | 0.78422023 |
| 64 | DYRK1A | 0.76631944 |
| 65 | RET | 0.76615580 |
| 66 | CCNB1 | 0.75305596 |
| 67 | CDK19 | 0.72903510 |
| 68 | LATS2 | 0.72607196 |
| 69 | FER | 0.72055039 |
| 70 | MAP3K6 | 0.71131307 |
| 71 | CDK14 | 0.69956637 |
| 72 | MAPK11 | 0.69767262 |
| 73 | SGK1 | 0.67952965 |
| 74 | MAPK13 | 0.67048382 |
| 75 | CDK15 | 0.66898815 |
| 76 | PRKCG | 0.66730218 |
| 77 | NTRK1 | 0.66426199 |
| 78 | NME2 | 0.66052693 |
| 79 | PAK3 | 0.65428244 |
| 80 | MET | 0.65185122 |
| 81 | CDK18 | 0.64362524 |
| 82 | MTOR | 0.63567328 |
| 83 | MAP2K6 | 0.63357585 |
| 84 | RPS6KL1 | 0.62109988 |
| 85 | RPS6KC1 | 0.62109988 |
| 86 | NEK9 | 0.61852846 |
| 87 | CAMK2A | 0.61562468 |
| 88 | RPS6KA3 | 0.60965534 |
| 89 | CAMK2D | 0.59943229 |
| 90 | CAMK4 | 0.58643258 |
| 91 | SIK1 | 0.58438126 |
| 92 | CAMK2B | 0.57832443 |
| 93 | GRK5 | 0.57575601 |
| 94 | TRIB3 | 0.55930965 |
| 95 | BRD4 | 0.54640607 |
| 96 | BMX | 0.54183707 |
| 97 | CDK11A | 0.53674783 |
| 98 | MOS | 0.53656622 |
| 99 | MAP2K1 | 0.52966311 |
| 100 | AKT3 | 0.51923250 |
| 101 | RPS6KA6 | 0.51740236 |
| 102 | PKN2 | 0.51677343 |
| 103 | PDK3 | 0.51288653 |
| 104 | PDK4 | 0.51288653 |
| 105 | CAMKK2 | 0.51052924 |
| 106 | PNCK | 0.50161542 |
| 107 | PRKAA2 | 0.50056939 |
| 108 | MAPK7 | 0.49245508 |
| 109 | PRKG1 | 0.48821737 |
| 110 | STK11 | 0.48361023 |
| 111 | TAOK1 | 0.46401462 |
| 112 | MAPK10 | 0.45890418 |
| 113 | PRKCZ | 0.45250061 |
| 114 | EPHA2 | 0.44979810 |
| 115 | AKT2 | 0.42853218 |
| 116 | BRAF | 0.42788912 |
| 117 | DMPK | 0.42393071 |
| 118 | PTK2 | 0.42345808 |
| 119 | PRKCA | 0.39666940 |
| 120 | DAPK3 | 0.39517219 |
| 121 | ERBB3 | 0.39272878 |
| 122 | PDPK1 | 0.38568026 |
| 123 | CDC42BPA | 0.38479767 |
| 124 | TNIK | 0.38259758 |
| 125 | CAMK2G | 0.38048289 |
| 126 | CDK8 | 0.37866060 |
| 127 | MAP3K11 | 0.37840278 |
| 128 | ARAF | 0.37081444 |
| 129 | ROCK1 | 0.37032068 |
| 130 | MAP3K10 | 0.35922217 |
| 131 | PDGFRA | 0.35153670 |
| 132 | ROCK2 | 0.34902202 |
| 133 | SGK3 | 0.32602092 |
| 134 | RPS6KA1 | 0.31322830 |
| 135 | TBK1 | 0.30342737 |
| 136 | DYRK1B | 0.28499882 |
| 137 | MAPK4 | 0.28067422 |
| 138 | IRAK2 | 0.25871191 |
| 139 | PDK2 | 0.25246283 |
| 140 | LATS1 | 0.24940257 |
| 141 | MAP3K1 | 0.24176884 |
| 142 | DDR2 | 0.24068108 |
| 143 | RPS6KB1 | 0.23186751 |
| 144 | ABL2 | 0.21336415 |
| 145 | EPHB1 | 0.21052752 |
| 146 | MAP3K3 | 0.19965427 |
| 147 | PAK1 | 0.19944943 |
| 148 | PRKD1 | 0.18265898 |
| 149 | YES1 | 0.17242129 |
| 150 | MAPKAPK2 | 0.17019886 |
| 151 | BCKDK | 0.14968571 |
| 152 | ERN1 | 0.14539487 |
| 153 | PRKACA | 0.13416951 |
| 154 | MAP2K2 | 0.13298866 |
| 155 | PRKACB | 0.12483785 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.40618699 |
| 2 | GABAergic synapse_Homo sapiens_hsa04727 | 2.98921198 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.77973271 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.72687175 |
| 5 | Morphine addiction_Homo sapiens_hsa05032 | 2.66028327 |
| 6 | Olfactory transduction_Homo sapiens_hsa04740 | 2.60092386 |
| 7 | Insulin secretion_Homo sapiens_hsa04911 | 2.49045147 |
| 8 | Circadian entrainment_Homo sapiens_hsa04713 | 2.45984872 |
| 9 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.45922337 |
| 10 | Galactose metabolism_Homo sapiens_hsa00052 | 2.24960336 |
| 11 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 2.17283221 |
| 12 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.12489048 |
| 13 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.10822490 |
| 14 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 2.10391377 |
| 15 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.09833619 |
| 16 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 2.06003054 |
| 17 | Salivary secretion_Homo sapiens_hsa04970 | 2.03258060 |
| 18 | Carbon metabolism_Homo sapiens_hsa01200 | 1.94158874 |
| 19 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.94041850 |
| 20 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.91003218 |
| 21 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.90355272 |
| 22 | Renin secretion_Homo sapiens_hsa04924 | 1.85772262 |
| 23 | Circadian rhythm_Homo sapiens_hsa04710 | 1.83879162 |
| 24 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.79050917 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78418472 |
| 26 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.78304426 |
| 27 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.70191085 |
| 28 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.64691972 |
| 29 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.64603835 |
| 30 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.59201713 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.58884816 |
| 32 | Long-term potentiation_Homo sapiens_hsa04720 | 1.52918224 |
| 33 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.50805107 |
| 34 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.49279901 |
| 35 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.43298995 |
| 36 | Taste transduction_Homo sapiens_hsa04742 | 1.41406915 |
| 37 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.37333507 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.37067916 |
| 39 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.35580267 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.29639006 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.28946288 |
| 42 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.28343234 |
| 43 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.27802406 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.26581255 |
| 45 | Bladder cancer_Homo sapiens_hsa05219 | 1.26082395 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.24667382 |
| 47 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.13023113 |
| 48 | Sulfur relay system_Homo sapiens_hsa04122 | 1.12473826 |
| 49 | Long-term depression_Homo sapiens_hsa04730 | 1.11921868 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.09987702 |
| 51 | Gap junction_Homo sapiens_hsa04540 | 1.07010018 |
| 52 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02841056 |
| 53 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00015885 |
| 54 | Glioma_Homo sapiens_hsa05214 | 0.99313189 |
| 55 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.98874922 |
| 56 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.97121971 |
| 57 | Lysine degradation_Homo sapiens_hsa00310 | 0.93343173 |
| 58 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.92734086 |
| 59 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.92644576 |
| 60 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.90182461 |
| 61 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90031492 |
| 62 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85665938 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.83090980 |
| 64 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.81325646 |
| 65 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.79203778 |
| 66 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.77782405 |
| 67 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.76837318 |
| 68 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.75659757 |
| 69 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.75056361 |
| 70 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74817025 |
| 71 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.73218789 |
| 72 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.72611509 |
| 73 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72581007 |
| 74 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.71940190 |
| 75 | Melanogenesis_Homo sapiens_hsa04916 | 0.71579409 |
| 76 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70891543 |
| 77 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.70839540 |
| 78 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.70139595 |
| 79 | Cocaine addiction_Homo sapiens_hsa05030 | 0.68768008 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.68031795 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.67674772 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.66548126 |
| 83 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.66517016 |
| 84 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.65077237 |
| 85 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.62505486 |
| 86 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.62069024 |
| 87 | Alzheimers disease_Homo sapiens_hsa05010 | 0.61813596 |
| 88 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.60213063 |
| 89 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.59230763 |
| 90 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58999625 |
| 91 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.58662071 |
| 92 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57996310 |
| 93 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.57641265 |
| 94 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.55937387 |
| 95 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.55648640 |
| 96 | Tight junction_Homo sapiens_hsa04530 | 0.55398329 |
| 97 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.54435016 |
| 98 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.53543173 |
| 99 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.51012487 |
| 100 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.50681141 |
| 101 | Adherens junction_Homo sapiens_hsa04520 | 0.50246157 |
| 102 | Axon guidance_Homo sapiens_hsa04360 | 0.49467536 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.48640161 |
| 104 | Bile secretion_Homo sapiens_hsa04976 | 0.47788355 |
| 105 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.46756168 |
| 106 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.46370216 |
| 107 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.46225938 |
| 108 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.46225220 |
| 109 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.45495744 |
| 110 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43643873 |
| 111 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.42922194 |
| 112 | Amoebiasis_Homo sapiens_hsa05146 | 0.42655243 |
| 113 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.42646843 |
| 114 | Insulin resistance_Homo sapiens_hsa04931 | 0.42328845 |
| 115 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.41770433 |
| 116 | Colorectal cancer_Homo sapiens_hsa05210 | 0.41323154 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.39339666 |
| 118 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.37791121 |
| 119 | Parkinsons disease_Homo sapiens_hsa05012 | 0.37534163 |
| 120 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.37033906 |
| 121 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.36923719 |
| 122 | Viral myocarditis_Homo sapiens_hsa05416 | 0.35921308 |
| 123 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.35154954 |
| 124 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.34080668 |
| 125 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.34062213 |
| 126 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.33466289 |
| 127 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.32527349 |
| 128 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.32342519 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31624285 |
| 130 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.31537296 |
| 131 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.31422572 |
| 132 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.30990097 |
| 133 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.30495968 |
| 134 | Endocytosis_Homo sapiens_hsa04144 | 0.29783584 |
| 135 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.29371065 |
| 136 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28449242 |
| 137 | ABC transporters_Homo sapiens_hsa02010 | 0.28022575 |
| 138 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.27971530 |
| 139 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.27512983 |
| 140 | Melanoma_Homo sapiens_hsa05218 | 0.25423321 |
| 141 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.24688916 |
| 142 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.24637158 |
| 143 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23292324 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.23108065 |
| 145 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.19664221 |
| 146 | Other glycan degradation_Homo sapiens_hsa00511 | 0.18306712 |

